SHANNON RADKOVICH: Open Payments
NPI 1215292099 · RANDOLPH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 28 payments from 11 companies in 2025. Trend: 2023 $122 · 2024 $189 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $96 |
| Novo Nordisk Inc | 4 | $75 |
| PFIZER INC. | 4 | $65 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Astellas Pharma US Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $33 |
| Bausch Health US, LLC | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Dexcom, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: TRINTELLIX, ELIQUIS, ZORYVE, Veozah, Ozempic, MOUNJARO, WELLBUTRIN, Dexcom G6 Transmitter.
Industry payments across NJ — which companies pay providers there.
